Samsung Biologics Co Ltd
KRX:207940
Samsung Biologics Co Ltd
Accumulated Depreciation
Samsung Biologics Co Ltd
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Samsung Biologics Co Ltd
KRX:207940
|
Accumulated Depreciation
-₩1.1T
|
CAGR 3-Years
-28%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
P
|
Peptron Inc
KOSDAQ:087010
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
ST Pharm Co Ltd
KOSDAQ:237690
|
Accumulated Depreciation
-₩146.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-16%
|
CAGR 10-Years
N/A
|
F
|
FutureChem Co Ltd
KOSDAQ:220100
|
Accumulated Depreciation
-₩26.4B
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-18%
|
CAGR 10-Years
N/A
|
L
|
LegoChem Biosciences Inc
KOSDAQ:141080
|
Accumulated Depreciation
-₩9.7B
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-26%
|
C
|
Cellivery Therapeutics Inc
KOSDAQ:268600
|
Accumulated Depreciation
-₩14.1B
|
CAGR 3-Years
-83%
|
CAGR 5-Years
-74%
|
CAGR 10-Years
N/A
|
See Also
What is Samsung Biologics Co Ltd's Accumulated Depreciation?
Accumulated Depreciation
-1.1T
KRW
Based on the financial report for Mar 31, 2024, Samsung Biologics Co Ltd's Accumulated Depreciation amounts to -1.1T KRW.
What is Samsung Biologics Co Ltd's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-32%
Over the last year, the Accumulated Depreciation growth was -30%. The average annual Accumulated Depreciation growth rates for Samsung Biologics Co Ltd have been -28% over the past three years , -32% over the past five years .